Reduced Time with Patients Concerns Residents

Share this content:
Reduced Time with Patients Concerns Residents
Reduced Time with Patients Concerns Residents

(HealthDay News) — Many U.S. medical residents are concerned about reduced face-time with patients and report that engaging patients in their own care is more challenging than anticipated, according to a report from the American Resident Project, sponsored by ThinkWellPoint.

To examine the issues that American residents face, the American Resident Project surveyed residents from across the country on various subjects, from public policy to patient engagement.

According to the report, the third most pressing issue reported was reduced "face-time" with patients. Many residents reported greater challenge than anticipated in their ability to manage time with patients (62%) and in engaging patients in their own care (53%).

RELATED: Practice Management

Most residents (80%) agreed that care coordination could improve chronic disease management, with the top benefit of coordinated care being the ability to better educate patients about prevention and disease management. Nearly half of residents (46%) agreed that the physician workforce shortage is likely to be the greatest challenge in helping to meet the needs of newly-insured patients.

"Most residents work in team-based settings and believe their medical school training prepared them well for working in this environment," according to the report. "More than one-third of residents view policies that promote team-based models as critical for improving care coordination within the system."

For more information, visit

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs